Geneva: The World Health Organization (WHO) announced that there is currently no conclusive scientific evidence linking the use of paracetamol during pregnancy to autism. This statement was made to counter claims by US President Donald Trump regarding the potential risks associated with the drug.

According to Philippines News Agency, the UN health agency highlighted that approximately 62 million people globally, or one in 127 individuals, are affected by autism spectrum disorder (ASD), which encompasses a range of conditions impacting brain development. Despite improvements in awareness and diagnosis, the causes of autism remain uncertain, with several factors potentially contributing to the disorder.

Earlier this week, President Trump suggested that taking Tylenol, known internationally as paracetamol, during pregnancy could lead to a "significantly increased risk of autism." In response, the WHO emphasized that extensive research conducted over the past ten years, including large-scale studies, has not demonstrated a consistent link between paracetamol use during pregnancy and autism.

The organization reiterated its stance that there is substantial evidence confirming that childhood vaccines do not cause autism. Various studies from different countries have consistently refuted claims of a connection, including those involving substances like thiomersal or aluminum.

Tedros Adhanom Ghebreyesus, WHO Director-General, advised on the social media platform X that women should adhere to medical guidance when considering medications during pregnancy and be especially cautious during the first trimester.